Pharmacokinetic Analysis of (111)In-Labeled Liposomal Doxorubicin in Murine Glioblastoma after Blood-Brain Barrier Disruption by Focused Ultrasound

The goal of this study was to evaluate the pharmacokinetics of targeted and untargeted (111)In-doxorubicin liposomes after these have been intravenously administrated to tumor-bearing mice in the presence of blood-brain barrier disruption (BBB-D) induced by focused ultrasound (FUS). An intracranial...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Feng-Yi, Wang, Hsin-Ell, Liu, Ren-Shyan, Teng, Ming-Che, Li, Jia-Je, Lu, Maggie, Wei, Ming-Cheng, Wong, Tai-Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445513/
https://www.ncbi.nlm.nih.gov/pubmed/23029030
http://dx.doi.org/10.1371/journal.pone.0045468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445513/
https://www.ncbi.nlm.nih.gov/pubmed/23029030
http://dx.doi.org/10.1371/journal.pone.0045468

Ejemplares similares